Imugene [ASX:IMU] Shares Rise as Management Seeks to Reassure Shareholders
Australian immune-oncology stock Imugene [ASX:IMU] released a letter this morning addressing shareholder discontent at the recent share price decline.
ASX:IMU
Imugene Share Price Up on Agreement with Merck and Pfizer (ASX:IMU)
The Imugene [ASX:IMU] share price is up 6% following a supply agreement update. Imugene, the biotech stock, gained 600% over the last 12 months.
Imugene Share Price Sink 7% after Flagging Three New Trials (ASX:IMU)
The Imugene [ASX:IMU] share price is floundering today on the back of an announcement regarding its HER-Vaxx immunotherapy in HER-2 positive gastric cancer trial.
Imugene Share Price Climbs 5% as Cancer Trial Closer to Commencing
Imugene Ltd [ASX:IMU] certainly finished 2020 with a bang. With a 5% lift in the IMU share price this morning, the stock is making waves once more. Today, it has since eased back from those record highs, but it is still faring well...
Imugene Share Price Lifts as Fresh Results Show Promise (ASX:IMU)
The Imugene Ltd [ASX:IMU] share price is trading 15% higher at time of writing. Rising on the back of new news from the biotech’s phase 2 trial. In what is now just the latest leg up for the company in the past month...